tiprankstipranks
Trending News
More News >
Atlantic International (ATLN)
NASDAQ:ATLN
US Market
Advertisement

Atlantic International (ATLN) AI Stock Analysis

Compare
35 Followers

Top Page

ATLN

Atlantic International

(NASDAQ:ATLN)

Select Model
Select Model
Select Model
Neutral 40 (OpenAI - 4o)
Rating:40Neutral
Price Target:
$2.00
▼(-1.96% Downside)
Atlantic International's overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The company's negative profitability and high leverage are significant risks, while the technical analysis suggests a bearish trend. Valuation metrics further highlight concerns due to the negative P/E ratio and lack of dividend yield.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for ATLN's diverse services, enhancing its market position and potential for future expansion.
Cash Flow Improvement
Improvement in free cash flow suggests better cash generation, providing ATLN with more resources for investment and debt management.
Diversified Revenue Streams
Diversification across sectors reduces dependency on a single market, providing ATLN with resilience against sector-specific downturns.
Negative Factors
High Leverage
High leverage increases financial risk, potentially limiting ATLN's ability to invest in growth opportunities and manage economic downturns.
Profitability Challenges
Profitability struggles indicate cost management issues, which can hinder ATLN's ability to sustain growth and invest in future projects.
Weak Capital Structure
A weak capital structure reflects financial instability, potentially affecting ATLN's creditworthiness and ability to raise capital.

Atlantic International (ATLN) vs. SPDR S&P 500 ETF (SPY)

Atlantic International Business Overview & Revenue Model

Company DescriptionAs of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
How the Company Makes MoneyAtlantic International generates revenue through multiple streams. Primarily, the company earns income from its telecommunications segment by offering mobile and internet services to consumers and businesses, charging subscription fees and usage-based charges. Additionally, its logistics division contributes significantly to revenue by providing supply chain management services and software solutions, which are billed based on service usage and contracts with corporate clients. The renewable energy sector adds another layer of revenue through the sale and installation of solar energy systems, with profitability driven by government incentives and long-term contracts with commercial clients. Strategic partnerships with technology providers and government agencies also enhance ATLN's revenue, enabling the company to leverage shared resources and expand its market reach.

Atlantic International Financial Statement Overview

Summary
Atlantic International shows strong revenue growth but faces significant challenges in profitability and financial stability. High leverage and negative equity are major concerns, despite some improvements in cash flow.
Income Statement
30
Negative
Atlantic International shows a significant revenue growth rate of 52.4% in the TTM, indicating strong top-line expansion. However, the company struggles with profitability, as evidenced by negative net profit, EBIT, and EBITDA margins. The gross profit margin is relatively low at 10.85%, suggesting challenges in cost management or pricing power.
Balance Sheet
20
Very Negative
The balance sheet reveals high leverage with a negative debt-to-equity ratio, indicating financial instability. The negative stockholders' equity and high return on equity percentage are concerning, reflecting potential financial distress. The equity ratio is also negative, highlighting a weak capital structure.
Cash Flow
35
Negative
Cash flow analysis shows a positive free cash flow growth rate of 2.715% in the TTM, suggesting some improvement in cash generation. However, the operating cash flow to net income ratio is low, indicating challenges in converting income into cash. The free cash flow to net income ratio is close to 1, showing that free cash flow is nearly equivalent to net income, which is a positive aspect.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue445.38M442.61M401.37M441.54M425.03M329.50K
Gross Profit48.34M47.18M46.88M54.21M54.41M158.69K
EBITDA-63.08M-113.10M1.44M11.94M12.18M-649.39K
Net Income-100.93M-135.48M-15.25M-3.22M-40.80M-1.05M
Balance Sheet
Total Assets110.26M122.75M126.67M8.41M10.74M694.04K
Cash, Cash Equivalents and Short-Term Investments83.41K678.68K1.35M6.22M9.95M0.00
Total Debt76.66M82.72M142.62M2.93M1.38M3.56M
Total Liabilities132.32M134.77M166.02M4.05M2.56M4.55M
Stockholders Equity-22.06M-12.02M-39.35M4.37M8.18M-3.85M
Cash Flow
Free Cash Flow3.29M-6.06M-9.16M-3.70M-2.00M-757.91K
Operating Cash Flow3.36M-5.99M-9.08M-3.66M-1.99M-757.91K
Investing Cash Flow-67.58K-73.46K-73.71K1.83M-5.99M0.00
Financing Cash Flow-4.60M5.38M8.79M0.0012.00M752.05K

Atlantic International Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.04
Price Trends
50DMA
2.96
Negative
100DMA
2.92
Negative
200DMA
3.10
Negative
Market Momentum
MACD
-0.16
Positive
RSI
38.01
Neutral
STOCH
9.51
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATLN, the sentiment is Negative. The current price of 2.04 is below the 20-day moving average (MA) of 2.52, below the 50-day MA of 2.96, and below the 200-day MA of 3.10, indicating a bearish trend. The MACD of -0.16 indicates Positive momentum. The RSI at 38.01 is Neutral, neither overbought nor oversold. The STOCH value of 9.51 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATLN.

Atlantic International Risk Analysis

Atlantic International disclosed 48 risk factors in its most recent earnings report. Atlantic International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Atlantic International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
51
Neutral
$205.24M-23.93%159.45%8.59%
48
Neutral
$255.66M-1.72-113.23%-41.87%-165.76%
44
Neutral
$182.65M-720.01%21.68%58.30%
41
Neutral
$102.04M-239.53%78.62%32.39%
40
Neutral
$119.68M109.65%77.14%
38
Underperform
$175.41M-122.81%14.08%1.34%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ATLN
Atlantic International
2.04
-3.15
-60.69%
ACRS
Aclaris Therapeutics
2.83
-1.13
-28.54%
MDXH
MDxHealth
3.69
1.71
86.36%
STIM
Neuronetics
1.49
0.38
34.23%
XGN
Exagen
7.90
3.71
88.54%
PRE
Prenetics Group
14.55
10.25
238.37%

Atlantic International Corporate Events

Executive/Board ChangesShareholder Meetings
Atlantic International Approves Key Proposals at AGM
Neutral
Nov 10, 2025

On November 7, 2025, Atlantic International held its Annual General Meeting, where 44.14% of the total outstanding shares were represented, surpassing the one-third quorum requirement. All proposals were approved, including the election of directors, a non-binding advisory on ‘Say on Pay,’ the frequency of future ‘Say on Pay’ votes set for every three years, the ratification of the company’s independent registered public accounting firm, and the approval of the 2025 Equity Omnibus Plan.

The most recent analyst rating on (ATLN) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Atlantic International stock, see the ATLN Stock Forecast page.

Business Operations and Strategy
Atlantic International Issues Cautionary Statement on Risks
Neutral
Oct 31, 2025

Atlantic International has issued a cautionary statement regarding forward-looking statements, emphasizing the inherent risks and uncertainties involved. The company highlights that these statements are based on current expectations and assumptions, which may not materialize due to various factors such as economic and competitive conditions, potentially impacting the company’s future operations and stakeholder interests.

The most recent analyst rating on (ATLN) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Atlantic International stock, see the ATLN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 30, 2025